Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Todos Medical Ltd (OP: TOMDF )

0.0180 UNCHANGED
Streaming Delayed Price Updated: 3:59 PM EDT, Sep 28, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.0180
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0180
Today's Range 0.0180 - 0.0180
52wk Range 0.0103 - 0.6440
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Todos Medical Announces USPTO Trademark Notice of Allowance for 3CL Protease Biomarker Diagnostics TolloTest
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Todos Medical Enters Into $50M Contract to Supply Tollovid and CBD Products to Retail Distributor Company Nerd Hemp
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Artificial Intelligence Supply Chain
Exposures Artificial Intelligence Supply Chain

Performance

YTD
-64.71%
-64.71%
1 Month
-52.25%
-52.25%
3 Month
+35.34%
+35.34%
6 Month
-6.25%
-6.25%
1 Year
-55.77%
-55.77%

More News

Read More
Todos Medical Announces NFL Hall of Famer Michael Irvin as Tollovid Sports Ambassador for #TolloUp Campaign
Via NewMediaWire
Exposures COVID-19
Todos Medical Announces Preprint of Long COVID Case Study Participant with Confirmed Microclot and Hyperactivated Platelets who Benefitted from Tollovid
Via NewMediaWire
Exposures COVID-19
Todos Medical Initiates Validation Plan for PCR-based Polio Testing at CLIA/CAP Laboratory Provista Diagnostics
Via NewMediaWire
Todos Medical & The Alchemists Kitchen to Host "Long COVID: An Integrated Approach" Event Benefitting Survivor Corps
Via NewMediaWire
Exposures COVID-19
Todos Medical's 3CL Protease Inhibitor Supplement Tollovid Featured in Wellness Magazine
Via NewMediaWire
Exposures COVID-19
Todos Medical Partner NLC Pharma Assigns IP for Tollovir, Tollovid, and TolloTest into JV 3CL Pharma
Via NewMediaWire
Exposures COVID-19
A Quick Look At The OTC Markets' Most-Active Securities In August - Here's What You Need to Know
Via Benzinga
Todos Medical CEO Discusses Long COVID Economic Impact with Moneta Advisory Managing Partner Marc LoPresti
Via NewMediaWire
Topics Economy
Exposures COVID-19 Economy
Todos Medical Announce Kingcarlx as Brand Ambassador for the Tollovid #TolloUp Lifestyle Campaign
Via NewMediaWire
Todos Medical Establishes Botanical Supplement Manufacturing Capabilities to Support Tollovid Global Expansion and Initiates CBD-A Production
Via NewMediaWire
Todos Medical Expands COVID Onsite School Sample Collection to Include MonkeyPox Testing
Via NewMediaWire
Exposures COVID-19
Todos Medical Announces Saliva-Only MonkeyPox Testing at CLIA/CAP Clinical Lab Provista Diagnostics
Via NewMediaWire
Todos Medical Enrolls Female Long COVID Patient Unable to Secure Testing While Symptomatic for MonkeyPox into Provista Diagnostics Case Study Series
Via NewMediaWire
Exposures COVID-19
Todos Medical Initiates MonkeyPox Diagnostic Case Studies After Being Approached by 4 Patients, Including 3 Women
Via NewMediaWire
Todos Medical Reports Second Quarter 2022 Financial Results and Business Update Conference Call on Tuesday, August 23 at 8:30am ET
Via NewMediaWire
Exposures COVID-19
Todos Medical Announces Commercialization of Lesion and Saliva-Based MonkeyPox PCR Testing
Via NewMediaWire
Exposures Product Safety
Todos Medical Announces Preprint of Data from First 100 Participants in IRB-waived Market Research Study of Supplementation with Tollovid in Long COVID
Via NewMediaWire
Exposures COVID-19
Todos Medical Reports Pre-Print of Publication Detailing Tollovid Supplementation Following COVID-19 mRNA Vaccination in Long COVID
Via NewMediaWire
Exposures COVID-19
Todos Medical Completes Trial Design for Tollovid Long COVID Clinical Study in Adults
Via NewMediaWire
Exposures COVID-19
Meet The Company Developing Advanved Blood Tests To Detect Cancer And Other Diseases
Via Benzinga
Todos Medical Announces PCR Validation of Wound and Respiratory Pathogen Panels at CLIA/CAP Lab Provista Diagnostics
Via NewMediaWire
Todos Medical Announces First Two Contracts for PCR-based MonkeyPox Testing at CLIA/CAP Clinical Testing Laboratory Provista Diagnostics
Via NewMediaWire
Exposures COVID-19
Todos Medical Announces First Long COVID Clinic Laboratory Services Agreement for Long COVID Panel Biomarker Partnership with Amerimmune Diagnostics
Via NewMediaWire
Exposures COVID-19
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.